Century Therapeutics (IPSC) Profit After Tax (2020 - 2026)
Century Therapeutics' (IPSC) quarterly Profit After Tax came in at -$21.6 million in Q1 2026, down 128.28% year-on-year from $76.5 million in Q1 2025, and down 11.2% on a QoQ basis from -$19.5 million in Q4 2025.
Century Therapeutics (IPSC) Profit After Tax (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Profit After Tax data on file, last reported at -$21.6 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 128.28% year-over-year to -$21.6 million in Q1 2026; TTM through Mar 2026 was -$108.1 million, a 382.49% decrease from a year earlier, with the FY2025 full-year figure at -$9.9 million, up 92.19% from the prior year.
- Profit After Tax for Q1 2026 stood at -$21.6 million, down from -$19.5 million in the prior quarter.
- Over the last five years, Profit After Tax for IPSC reached as high as $76.5 million in Q1 2025 and fell as low as -$38.0 million in Q4 2023.
- Historically, Profit After Tax has averaged -$24.9 million across 5 years, with a median of -$31.2 million in 2024.
- Across the five-year window, Profit After Tax soared 372.76% in 2025 and plunged 128.28% in 2026, its largest moves.
- Year by year, Profit After Tax stood at -$30.5 million in 2022, then decreased by 24.37% to -$38.0 million in 2023, then rose by 3.89% to -$36.5 million in 2024, then soared by 46.68% to -$19.5 million in 2025, then fell by 11.2% to -$21.6 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$21.6 million in Q1 2026, -$19.5 million in Q4 2025, and -$34.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Century Therapeutics | 406.30 Mn | 271.49 Mn | - | -21.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.65 Mn |
| Dec 31, 2025 | -19.47 Mn |
| Sep 30, 2025 | -34.42 Mn |
| Jun 30, 2025 | -32.54 Mn |
| Mar 31, 2025 | 76.54 Mn |
| Dec 31, 2024 | -36.51 Mn |
| Sep 30, 2024 | -31.23 Mn |
| Jun 30, 2024 | -31.21 Mn |
| Mar 31, 2024 | -28.06 Mn |
| Dec 31, 2023 | -37.98 Mn |
| Sep 30, 2023 | -32.82 Mn |
| Jun 30, 2023 | -33.29 Mn |
| Mar 31, 2023 | -31.26 Mn |
| Dec 31, 2022 | -30.54 Mn |
| Sep 30, 2022 | -30.92 Mn |
| Jun 30, 2022 | -30.99 Mn |
| Mar 31, 2022 | -37.51 Mn |
| Dec 31, 2021 | -28.78 Mn |
| Sep 30, 2021 | -26.01 Mn |
| Jun 30, 2021 | -23.27 Mn |